Carolina Solis-Herrera, MD, assistant professor of medicine at The University of Texas Health Science Center at San Antonio, is the recipient of the prestigious 2021 Doris Duke Charitable Foundation (DDCF) Clinical Scientist Development Award.  Dr. Solis-Herrera’s innovative and high-impact research focuses on sodium-glucose transport protein 2 (SGLT2) inhibitors, a class of medications used to treat Type 2 diabetes. Hers was the only diabetes-related project among the 20 selected from a total of 254 submissions from around the country and the only project led by a physician-scientist in the Southwestern United States, including Texas. Click here to hear Dr. Solis-Herrera explain the innovative study by watching a three-minute video.